跳至主要内容
临床试验/JPRN-UMIN000010880
JPRN-UMIN000010880已完成未知

Effect of Linagliptin on daily glucose excursion in Continuous Glucose Monitoring of Type2 diabetic patients - L-CGM

Japan society of Patient Reported Outcome0 个研究点目标入组 100 人开始时间: 2013年6月5日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Type 1 and secondary diabetes 2.Severe infectious disease, before or after surgery, and severe trauma 3.Events of myocardial infarction, cerebral stroke, cerebral infarction and TIA in the past 3 month. 4.Moderate or severer heart failure(NYHA/New York Heart Association stage III or severer) 5.Severe liver dysfunction (ALT,AST and ALP face 3 times the normal level) 6.Past medical history of hypersensitivity to investigational drugs. 7.Patients addicted to alcohol and drugs. 8.Pregnant, lactating, and possibly pregnant women and those planning to become pregnant. 9.Patients with cancer. 10.Patent receiving steroid therapy with inflammatory affection. 11.Past medical history of abdominal operation and ileus. 12.Judged as ineligible by clinical investigators.

研究者

发起方
Japan society of Patient Reported Outcome

相似试验